Description
WCCT Global is currently conducting a clinical research trial of an investigational medicine that
is intended to reverse the antiplatelet effects of an already-approved drug called Brilinta®
(ticagrelor) in generally healthy older adults.
Qualifications:
• Males and females who are in good general health or who have chronic, stable, and
generally well controlled medical conditions
• Age 50 to 80 years old
• Body weight between 111 lbs – 264 lbs (50kg – 120kg)
• Available for 1 screening visit, one 5-night stay, and 2 follow-up visits
You May Receive:
• Compensation up to $4,400
• Study related procedures at no cost
* Onsite COVID-19 testing procedures will be conducted
To sign up, please visit us at
Discussion
By posting you agree to the Terms and Privacy Policy.